Early use of low-molecular heparin to prevent portal thrombosis after splenectomy and pericardial devasculariza-tion in patients with portal hypertension

Jie KUANG,Weiping YANG,Hao CHEN,Chenghong PENG,Hongwei LI

DOI: https://doi.org/10.16139/j.1007-9610.2015.02.010

2015-01-01

Abstract:Objective To investigate the effect and safety of early use of low-molecular heparin for the prevention of portal thrombosis after splenectomy and pericardial devascularization. Methods One hundred and six patients with portal hypertension experienced splenectomy and pericardial devascularization were analyzed between January 2011 and June 2013. These patients were divided into heparin group (n=41) and non-heparin group (n=65). In the heparin group, one dose of enoxaparin was used two weeks since the first day after operation. Results The parameters including sex, age, cause, Child-Pugh classification, perioperative platelet count, preoperative indexes of D-dimer, portal vein diameter and flow and velocity, free portal pressure before and after splenectomy with devascularization had no significant difference be-tween two groups (P>0.05). The rate of portal vein thrombosis in heparin group was lower significantly comparing with that in non-heparin group (17.1%vs 43.1%, P=0.006). The platelet count of the patients with portal thrombosis was more than that of the patients without portal thrombosis significantly (608.9×109/L vs 302.4×109/L, P<0.001). There was no incision hemorrhage and upper gastrointestinal bleeding in heparin group. Conclusions Early use of low-molecular heparin could reduce the incidence of portal vein thrombosis significantly without safe problem for the patients with splenectomy and pericardial devascularization.